no. Blinded
- Forums
- ASX - By Stock
- Ann: First patient imaged in Phase III AMPLIFY trial
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
2.23%
!
$2.19

no. Blinded
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.19 |
Change
-0.050(2.23%) |
Mkt cap ! $703.7M |
Open | High | Low | Value | Volume |
$2.24 | $2.28 | $2.18 | $2.901M | 1.308M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 105730 | $2.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.19 | 49265 | 59 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 83518 | 2.180 |
21 | 228779 | 2.170 |
16 | 102119 | 2.160 |
12 | 57738 | 2.150 |
9 | 229963 | 2.140 |
Price($) | Vol. | No. |
---|---|---|
2.190 | 45758 | 49 |
2.200 | 30972 | 36 |
2.210 | 28580 | 15 |
2.220 | 16977 | 7 |
2.230 | 15758 | 7 |
Last trade - 15.29pm 18/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online